Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • ONS Congress
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    The Case of the Pregnancy Predicament
    Clinical practice
    The Case of the Pregnancy Predicament
    August 02, 2019
    Sex Is an Important Dimension of Cancer Psychosocial Care That We Need to Stop Neglecting
    Sexual/reproductive issues
    Sex Is an Important Dimension of Cancer Psychosocial Care That We Need to Stop Neglecting
    July 26, 2019
    Nurses Offer Wellness Checks to Congressional Staffers
    Cancer risk prevention
    Nurses Offer Wellness Checks to Congressional Staffers
    July 25, 2019
    Nurse Meets With New Hampshire Lawmakers to Connect Them to ONS Health Policy
    Health Policy
    Nurse Meets With New Hampshire Lawmakers to Connect Them to ONS Health Policy
    July 24, 2019
    Continued Conversation Shows That Nurses Need More Genetics Education
    Genetics & genomics
    Continued Conversation Shows That Nurses Need More Genetics Education
    July 19, 2019
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    Hyperthyroidism Treatment Linked to Increased Cancer Death Risk
    Cancer risk factors

    Hyperthyroidism Treatment Linked to Increased Cancer Death Risk

    Radioactive iodine treatment for hyperthyroidism is associated with long-term risk of death from solid cancers, particularly breast cancer, according to the results of a study published in JAMA Internal Medicine. 
     

    August 21, 2019
    CAR T Cells Show Promise in Solid Tumors
    Research

    CAR T Cells Show Promise in Solid Tumors

    Two recent studies demonstrated CAR T-cell therapy activity in certain types of solid tumors, according to results presented at the American Society of Clinical Oncology annual meeting. The CAR T cells used new targets outside of the CD19 targets used for the therapy’s current approvals in leukemia and lymphoma. 
     

    August 14, 2019
    Immunotherapy Experts Identify Key Oncology Nursing Priorities at ONS Summit
    Immunotherapy

    Immunotherapy Experts Identify Key Oncology Nursing Priorities at ONS Summit

    Care coordination, appropriate adverse event assessment and treatment, and rapid, continuous learning are essential priorities for oncology nurses to care for patients receiving immunotherapy, according to the experts who participated in ONS’s immunotherapy summit in March 2018. 

    August 13, 2019
    Clinical Trial Participants Average 6.5 Years Younger Than Actual Cancer Populations
    Research

    Clinical Trial Participants Average 6.5 Years Younger Than Actual Cancer Populations

    For the four most common cancer sites (breast, prostate, colorectal, and lung cancer), the median age of patients in clinical trials is an average of 6.5 years younger than the median age of patients diagnosed with that cancer. And the age disparity is worsening, researchers reported in JAMA Oncology. 

    August 07, 2019
    Incidence of Aggressive Uterine Cancer Is Increasing
    Research

    Incidence of Aggressive Uterine Cancer Is Increasing

    U.S. incidence rates for aggressive uterine cancer subtypes are quickly rising for women aged 30-70, especially among non-Hispanic black women, according to results of a study published in the Journal of Clinical Oncology.

    July 24, 2019
    High Fitness Linked to Lower Risk and Mortality in Lung and Colorectal Cancers
    Research

    High Fitness Linked to Lower Risk and Mortality in Lung and Colorectal Cancers

    Adults with the highest cardiorespiratory fitness levels have a reduced risk for lung and colorectal cancer—and a lower risk of death if they do develop the cancers, according to findings from a study published in Cancer.

    July 17, 2019
    Magnet Status Benefits Physicians, Too
    Research

    Magnet Status Benefits Physicians, Too

    Achieving Magnet recognition is the gold standard of a nursing program, demonstrating that an organization’s nursing leaders have established nursing excellence to improve outcomes for patients. And now the results of a new study published in Harvard Business Review show that excellent nurses are positively linked to physicians’ performance as well.

    July 10, 2019
    Collaboration Is Key to CAR T-Cell Therapy Management Across Settings
    Immunotherapy

    Collaboration Is Key to CAR T-Cell Therapy Management Across Settings

    As of February 2019, only 160 institutions across the United States are certified to administer CAR T-cell therapy, meaning many eligible patients may need to be referred to a treatment center outside of the local ambulatory or community cancer center where they had previously received treatment. The transition from primary oncologist to certified center and back again requires careful coordination to ensure important steps and information aren’t lost.

    July 09, 2019
    The Work We Do Now Affects Healthcare’s Future
    Nurse empowerment

    The Work We Do Now Affects Health Care’s Future

    The World Health Organization designated 2020 internationally as the Year of the Nurse and Midwife in honor of Florence Nightingale’s 200th birthday. To celebrate the work that nurses do globally, nursing organizations around the world are creating programs that offer recognition—as well as education, training, and professional development.

    July 08, 2019
    Test Predicts Which Women Will Benefit From Chemo for Breast Cancer
    Breast cancer

    Test Predicts Which Women Will Benefit From Chemo for Breast Cancer

    A prediction test accurately identifies which women with estrogen receptor (ER)-positive, HER2-negative breast cancer will benefit from adjuvant chemotherapy, according to the results of a study published in Breast Cancer Research and Treatment. 
     

    July 03, 2019
    Access to Care and Nondiscrimination Are Two Key Ways to Address Cancer Disparities, According to ONS and ANA Position Statements
    Cancer health disparities

    Access to Care and Nondiscrimination Are Two Key Ways to Address Cancer Disparities, According to ONS and ANA Position Statements

    Cancer knows no race, color, nationality, or ethnicity. But although any person may one day develop cancer, incidence and mortality rates for some cancers are disproportionately higher in certain racial, ethnic, geographic, or socioeconomic groups. Here are just a few of the many identified cancer disparities, according to the National Cancer Institute.

    June 27, 2019
    New CAR T-Cell Targets Show Safe Results in Early Clinical Trials
    Research

    New CAR T-Cell Targets Show Safe Results in Early Clinical Trials

    Findings from two phase I clinical trials presented at the American Association for Cancer Research 2019 annual meeting indicate that targeting CAR T cells against mesothelin for advanced solid tumors and HER2 for advanced sarcoma is safe and shows clinical antitumor activity.

    June 26, 2019
    Early Studies Show Cancer Vaccines Are Promising for Lynch Syndrome, Cervical Lesions
    Research

    Early Studies Show Cancer Vaccines Are Promising for Lynch Syndrome, Cervical Lesions

    Findings from two recent studies underscore that cancer vaccines may be a larger part of the next wave of novel cancer therapies. According to data presented at the American Association for Cancer Research 2019 annual meeting, vaccination with as few as four tumor antigens generated antigen-specific responses, reduced intestinal tumors, and improved survival in a mouse model of Lynch syndrome. 

    June 19, 2019
    FDA Links Breast Implants to Increased ALCL Risk
    U.S. Food and Drug Administration (FDA)

    FDA Links Breast Implants to Increased ALCL Risk

    People with breast implants have a risk of developing breast implant-associated anaplastic large cell lymphoma (ALCL), the U.S. Food and Drug Administration (FDA) announced in April 2019. Typically the cancer is limited to the scar tissue and fluid near an implant, but some patients experience spread throughout the body. The risk increases with textured implants in particular.

    June 12, 2019
    Survivorship Considerations After CAR T-Cell Therapy
    Immunotherapy

    Survivorship Considerations After CAR T-Cell Therapy

    As more patients receive treatment with chimeric antigen receptor (CAR) T-cell therapy, oncology nurses will need to be aware of the long-term effects of treatment that may persist into survivorship. However, because the treatment is so new, studies measuring those patient-reported concerns are still forthcoming. The majority of today’s recommendations for survivorship management are based on experts’ clinical experience.

    June 11, 2019
    Less Toxic CAR T-Cell Therapy May Be on the Horizon
    Treatments

    Less Toxic CAR T-Cell Therapy May Be on the Horizon

    Preliminary results reported in Nature Medicine showed that a redesigned CAR T-cell therapy produced complete response with no severe toxicities in 25 patients with refractory B-cell lymphoma.

    June 05, 2019
    FDA Cautions That Robotic Devices Are Not Approved for Mastectomy or Other Women’s Cancer Surgeries
    U.S. Food and Drug Administration (FDA)

    FDA Cautions That Robotic Devices Are Not Approved for Mastectomy or Other Women’s Cancer Surgeries

    Because of limited preliminary evidence that the use of robotic-assisted surgical devices for treatment or prevention of women’s cancers may be associated with diminished long-term survival, the U.S. Food and Drug Administration (FDA) issued a reminder warning to healthcare providers and the public in February 2019 that the technique has not been FDA approved for this purpose.

    May 22, 2019
    Commission on Cancer to Revise Standards for Cancer Program Accreditation
    Standards

    Commission on Cancer to Revise Standards for Cancer Program Accreditation

    The Commission on Cancer (CoC), an organizational consortium of which ONS is a governing member, provides standards for cancer programs to follow to achieve a high level of continuous quality improvement. Last updated in 2016, the standards are currently undergoing analysis and revision, and CoC is seeking public comments until June 3, 2019.

    May 20, 2019
    Gut Microbiome Diversity May Improve Response to Melanoma Immunotherapy
    Research

    Gut Microbiome Diversity May Improve Response to Melanoma Immunotherapy

    A high-fiber diet leading to higher gut microbiome diversity may improve response to anti-PD-1 immunotherapy in patients with melanoma, according to the results of a new study presented at the 2019 American Association for Cancer Research Annual Meeting in Atlanta, GA. 

    May 15, 2019
    Liquid Biopsy Equivalent to Tissue for NSCLC
    Lung Cancer

    Liquid Biopsy Equivalent to Tissue for NSCLC

    With faster and equally accurate results, liquid biopsy may be an option for identifying guideline-recommended targeted therapies for non-small cell lung cancer (NSCLC), according to findings presented at the 2019 American Association for Cancer Research Annual Meeting in Atlanta, GA. 

    May 08, 2019
    New Genetics Service Delivery Models Help Patients Access Genetic Counseling
    Genetics & genomics

    New Genetics Service Delivery Models Help Patients Access Genetic Counseling

    As genetic and genomic testing become more common—and complex—in cancer diagnosis and treatment decisions, more efficient and accessible ways of providing comprehensive genetic care are needed. In their article in the February 2019 issue of the Clinical Journal of Oncology Nursing, Pierle and Mahon discussed the findings from their literature review, specifically pertaining to genetics care services across the cancer continuum, patient and system barriers to accessing care, new service delivery models, and oncology nurses’ role in providing comprehensive cancer genetics care services.

    May 07, 2019
    Kentucky Illustrates Success of Medicaid Expansion
    Medical reimbursement

    Kentucky Illustrates Success of Medicaid Expansion

    The state of Kentucky has seen some of the most success in reducing its uninsured rate thanks to the Affordable Care Act’s Medicaid expansion that took effect on January 1, 2014. The results of a new study, published in the Journal of the American College of Surgeons, showed that as the number of insured individuals rose, so too did important cancer screening rates.

    May 01, 2019
    Updated Scope and Standards Represent Key Foci of Oncology Nursing Practice
    Clinical practice

    Updated Scope and Standards Represent Key Foci of Oncology Nursing Practice

    To ensure that the Oncology Nursing: Scope and Standards of Practice are consistent with overall nursing standards and to increase the visibility of the oncology nursing standards in the greater nursing and healthcare communities, ONS released an updated version of its reference book in March 2019. The American Nurses Association (ANA) recognizes oncology nursing as a nursing specialty, and the new edition carries ANA’s approval of the oncology nursing scope of practice and acknowledgement of the oncology nursing standards of practice.

    April 26, 2019
    Tachycardia Tied to Higher Mortality in Patients With Cancer
    Symptom management

    Tachycardia Tied to Higher Mortality in Patients With Cancer

    Rates of all-cause mortality in patients with cancer increase in the presence of unexplained sinus tachycardia, the results of a new study show. Researchers presented the findings at the Advancing Cardiovascular Care of the Oncology Patient conference held January 2019 in Washington, DC.

    April 24, 2019
    Guidelines Insufficient for Prostate Cancer Germline Genetic Testing
    Research

    Guidelines Insufficient for Prostate Cancer Germline Genetic Testing

    According to researchers, only 43.8% of positive genetic variants detected in men with prostate cancer had corresponding recommendations for germline testing in National Comprehensive Cancer Network (NCCN) guidelines. The findings were published in JAMA Oncology.

    April 17, 2019
    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9
    • Next page
    • Last page Last »
    picture of the author
    Elisa Becze BA, ELS, Editor
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2019 Oncology Nursing Society
    Back to Top ▲